Failla Michelle D, Conley Yvette P, Wagner Amy K
Center for Neuroscience, University of Pittsburgh, Pittsburgh, PA, USA.
Department of Human Genetics, School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA Health Promotion & Development, School of Nursing, University of Pittsburgh, Pittsburgh, PA, USA Department of Physical Medicine and Rehabilitation, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Neurorehabil Neural Repair. 2016 Jan;30(1):83-93. doi: 10.1177/1545968315586465. Epub 2015 May 15.
Older adults have higher mortality rates after severe traumatic brain injury (TBI) compared to younger adults. Brain-derived neurotrophic factor (BDNF) signaling is altered in aging and is important to TBI given its role in neuronal survival/plasticity and autonomic function. Following experimental TBI, acute BDNF administration has not been efficacious. Clinically, genetic variation in BDNF (reduced signaling alleles: rs6265, Met-carriers; rs7124442, C-carriers) can be protective against acute mortality. Postacutely, these genotypes carry lower mortality risk in older adults and greater mortality risk among younger adults.
Investigate BDNF levels in mortality/outcome following severe TBI in the context of age and genetic risk.
Cerebrospinal fluid (CSF) and serum BDNF were assessed prospectively during the first week following severe TBI (n = 203) and in controls (n = 10). Age, BDNF genotype, and BDNF levels were assessed as mortality/outcome predictors.
CSF BDNF levels tended to be higher post-TBI (P = .061) versus controls and were associated with time until death (P = .042). In contrast, serum BDNF levels were reduced post-TBI versus controls (P < .0001). Both gene * BDNF serum and gene * age interactions were mortality predictors post-TBI in the same multivariate model. CSF and serum BDNF tended to be negatively correlated post-TBI (P = .07).
BDNF levels predicted mortality, in addition to gene * age interactions, suggesting levels capture additional mortality risk. Higher CSF BDNF post-TBI may be detrimental due to injury and age-related increases in pro-apoptotic BDNF target receptors. Negative CSF and serum BDNF correlations post-TBI suggest blood-brain barrier transit alterations. Understanding BDNF signaling in neuronal survival, plasticity, and autonomic function may inform treatment.
与年轻成年人相比,老年成年人在重度创伤性脑损伤(TBI)后死亡率更高。脑源性神经营养因子(BDNF)信号在衰老过程中发生改变,鉴于其在神经元存活/可塑性和自主神经功能中的作用,对TBI很重要。实验性TBI后,急性给予BDNF无效。临床上,BDNF的基因变异(信号降低等位基因:rs6265,携带Met者;rs7124442,携带C者)可预防急性死亡。急性后期,这些基因型在老年成年人中死亡风险较低,而在年轻成年人中死亡风险较高。
在年龄和遗传风险背景下,研究重度TBI后死亡率/预后中的BDNF水平。
在重度TBI后的第一周(n = 203)及对照组(n = 10)中,前瞻性评估脑脊液(CSF)和血清BDNF。将年龄、BDNF基因型和BDNF水平评估为死亡率/预后预测指标。
与对照组相比,TBI后脑脊液BDNF水平倾向于更高(P = 0.061),且与直至死亡的时间相关(P = 0.042)。相反,与对照组相比,TBI后血清BDNF水平降低(P < 0.0001)。在同一多变量模型中,基因BDNF血清和基因年龄相互作用均为TBI后死亡率预测指标。TBI后脑脊液和血清BDNF倾向于呈负相关(P = 0.07)。
除基因*年龄相互作用外,BDNF水平可预测死亡率,提示其水平反映了额外的死亡风险。TBI后脑脊液BDNF水平较高可能因损伤和促凋亡BDNF靶受体的年龄相关增加而有害。TBI后脑脊液和血清BDNF的负相关提示血脑屏障转运改变。了解BDNF在神经元存活、可塑性和自主神经功能中的信号传导可能为治疗提供依据。